相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Kinetics and Risk Factors of Relapse after Allogeneic Stem Cell Transplantation in Children with Leukemia: A Long-Term Follow-Up Single-Center Study
Blanca Molina et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Prognostic Factors in Lung Transplantation After Hematopoietic Stem Cell Transplantation
Toyofumi F. Chen-Yoshikawa et al.
TRANSPLANTATION (2018)
An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication
V. V. Maka et al.
BONE MARROW TRANSPLANTATION (2017)
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
P. Tsirigotis et al.
BONE MARROW TRANSPLANTATION (2016)
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Mark Greer et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation
Christoph Schmid et al.
BLOOD (2015)
A consensus document for the selection of lung transplant candidates: 2014-An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
David Weill et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation
Guang-Shing Cheng et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis
M. Stern et al.
LEUKEMIA (2014)
Prevalence of Hematopoietic Cell Transplant Survivors in the United States
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Trends in Use of and Survival after Autologous Hematopoietic Cell Transplantation in North America, 1995-2005: Significant Improvement in Survival for Lymphoma and Myeloma during a Period of Increasing Recipient Age
Philip L. McCarthy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study
Toru Oga et al.
RESPIRATORY RESEARCH (2012)
Less Maintenance Immunosuppression in Lung Transplantation Following Hematopoietic Stem Cell Transplantation From the Same Living Donor
F. Chen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children
N. Nishio et al.
BONE MARROW TRANSPLANTATION (2009)
Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantation
G Stussi et al.
TRANSPLANTATION PROCEEDINGS (2005)
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
F Patriarca et al.
BONE MARROW TRANSPLANTATION (2004)
Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes
AZ Dudek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect
E Sakaida et al.
BLOOD (2003)
Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation
B Afessa et al.
BONE MARROW TRANSPLANTATION (2001)
ABO-incompatibility in solid organ transplantation
L Rydberg
TRANSFUSION MEDICINE (2001)